Bisson J, Gordillo M, Kumar R, de Silva N, Yang E, Banks K
Elife. 2025; 13.
PMID: 40080060
PMC: 11906159.
DOI: 10.7554/eLife.100797.
Karami N, Taei A, Hassani S, Alizadeh N, Eftekhari-Yazdi P, Hassani F
Sci Rep. 2025; 15(1):5006.
PMID: 39929940
PMC: 11811121.
DOI: 10.1038/s41598-025-89460-9.
Stougiannou T, Christodoulou K, Karangelis D
Biomedicines. 2025; 12(12.
PMID: 39767621
PMC: 11726960.
DOI: 10.3390/biomedicines12122714.
Jensen G, Wang X, Kuempel J, Chen Z, Yu W, Palaskas N
J Mol Cell Cardiol Plus. 2025; 10.
PMID: 39742339
PMC: 11687339.
DOI: 10.1016/j.jmccpl.2024.100122.
Jang J, Jung H, Jeong J, Jeon J, Lee K, Jang H
Heliyon. 2024; 10(20):e38714.
PMID: 39640743
PMC: 11620051.
DOI: 10.1016/j.heliyon.2024.e38714.
Highly efficient generation of self-renewing trophoblast from human pluripotent stem cells.
Slamecka J, Ryu S, Tristan C, Chu P, Weber C, Deng T
iScience. 2024; 27(10):110874.
PMID: 39386760
PMC: 11462042.
DOI: 10.1016/j.isci.2024.110874.
SMYD1 modulates the proliferation of multipotent cardiac progenitor cells derived from human pluripotent stem cells during myocardial differentiation through GSK3β/β-catenin&ERK signaling.
Chang Y, Bai R, Zhang Y, Lu W, Ma S, Zhu M
Stem Cell Res Ther. 2024; 15(1):350.
PMID: 39380045
PMC: 11462858.
DOI: 10.1186/s13287-024-03899-7.
GATA6 regulates WNT and BMP programs to pattern precardiac mesoderm during the earliest stages of human cardiogenesis.
Bisson J, Gordillo M, Kumar R, de Silva N, Yang E, Banks K
bioRxiv. 2024; .
PMID: 39026742
PMC: 11257636.
DOI: 10.1101/2024.07.09.602666.
Monocytes prevent apoptosis of iPSCs and promote differentiation of kidney organoids.
Pecksen E, Tkachuk S, Schroder C, Vives Enrich M, Neog A, Johnson C
Stem Cell Res Ther. 2024; 15(1):132.
PMID: 38702808
PMC: 11069262.
DOI: 10.1186/s13287-024-03739-8.
Progress in preclinical research on induced pluripotent stem cell therapy for acute myocardial infarction.
Cai S, Dai Q
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(2):244-253.
PMID: 38594961
PMC: 11057988.
DOI: 10.3724/zdxbyxb-2023-0402.
Matrix-free human pluripotent stem cell manufacturing by seed train approach and intermediate cryopreservation.
Ullmann K, Manstein F, Triebert W, Kriedemann N, Franke A, Teske J
Stem Cell Res Ther. 2024; 15(1):89.
PMID: 38528578
PMC: 10964510.
DOI: 10.1186/s13287-024-03699-z.
Improving cardiac differentiation of human pluripotent stem cells by targeting ferroptosis.
Aalders J, Leger L, Hassannia B, Goossens V, Vanden Berghe T, van Hengel J
Regen Ther. 2024; 27:21-31.
PMID: 38496011
PMC: 10940893.
DOI: 10.1016/j.reth.2024.02.007.
Identification of Maleimide-Fused Carbazoles as Novel Noncanonical Bone Morphogenetic Protein Synergizers.
Riege D, Herschel S, Heintze L, Fenkl T, Wesseler F, Sievers S
ACS Pharmacol Transl Sci. 2023; 6(8):1207-1220.
PMID: 37588754
PMC: 10426274.
DOI: 10.1021/acsptsci.3c00103.
Harnessing developmental cues for cardiomyocyte production.
Maas R, van den Dolder F, Yuan Q, van der Velden J, Wu S, Sluijter J
Development. 2023; 150(15).
PMID: 37560977
PMC: 10445742.
DOI: 10.1242/dev.201483.
A live-cell image-based machine learning strategy for reducing variability in PSC differentiation systems.
Yang X, Chen D, Sun Q, Wang Y, Xia Y, Yang J
Cell Discov. 2023; 9(1):53.
PMID: 37280224
PMC: 10244346.
DOI: 10.1038/s41421-023-00543-1.
Xeno-Free Integrated Platform for Robust Production of Cardiomyocyte Sheets from hiPSCs.
Dias T, Baltazar T, Pinto S, Fernandes T, Fernandes F, Diogo M
Stem Cells Int. 2022; 2022:4542719.
PMID: 36467280
PMC: 9712013.
DOI: 10.1155/2022/4542719.
A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming.
Lyra-Leite D, Gutierrez-Gutierrez O, Wang M, Zhou Y, Cyganek L, Burridge P
STAR Protoc. 2022; 3(3):101560.
PMID: 36035804
PMC: 9405110.
DOI: 10.1016/j.xpro.2022.101560.
High-efficient serum-free differentiation of endothelial cells from human iPS cells.
Hamad S, Derichsweiler D, Gaspar J, Brockmeier K, Hescheler J, Sachinidis A
Stem Cell Res Ther. 2022; 13(1):251.
PMID: 35690874
PMC: 9188069.
DOI: 10.1186/s13287-022-02924-x.
Bioengineering Strategies to Create 3D Cardiac Constructs from Human Induced Pluripotent Stem Cells.
Varzideh F, Mone P, Santulli G
Bioengineering (Basel). 2022; 9(4).
PMID: 35447728
PMC: 9028595.
DOI: 10.3390/bioengineering9040168.
Improving Generation of Cardiac Organoids from Human Pluripotent Stem Cells Using the Aurora Kinase Inhibitor ZM447439.
Lee S, Kim H, Kim S, Lee H
Biomedicines. 2021; 9(12).
PMID: 34944767
PMC: 8698385.
DOI: 10.3390/biomedicines9121952.